{"id":25475,"date":"2020-08-20T12:24:28","date_gmt":"2020-08-20T16:24:28","guid":{"rendered":"http:\/\/stateofthenation.co\/?p=25475"},"modified":"2020-08-20T12:24:28","modified_gmt":"2020-08-20T16:24:28","slug":"nihgate-niaid-officials-stand-to-make-millions-from-moderna-vaccine","status":"publish","type":"post","link":"https:\/\/stateofthenation.co\/?p=25475","title":{"rendered":"NIHgate: NIAID Officials Stand to Make Millions from Moderna Vaccine"},"content":{"rendered":"

LEGAL UPDATE: Informed Consent Action Network<\/h2>\n

<\/p>\n

Submitted by ICAN<\/p>\n\n\n\n
\n\n\n\n
\n
\n\n\n\n
\n
\"\"<\/div>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n
\n
\n\n\n\n
\n
<\/div>\n
\n
\n
ICAN can now officially confirm that officials within the National Institute of Health (NIH) who are working to develop a vaccine for novel coronavirus (COVID-19) stand to personally earn millions of dollars from sales of this vaccine.<\/div>\n
<\/div>\n
When government officials will profit from the sale of a product, there is cause for concern regarding their licensure and promotion of that product.<\/div>\n
<\/div>\n
The first vaccine for COVID-19 to begin trials in the United States is mRNA-1273<\/a>. This experimental vaccine was developed by Dr. Anthony Fauci\u2019s National Institute of Allergy and Infectious Disease (NIAID), which is part of the NIH, along with a biotech company, Moderna Inc., the company that will sell this product to the public.<\/div>\n
<\/div>\n
To receive a share of the profit from the sale of mRNA-1273, the inventors of this product within NIAID would submit an Employee Invention Report<\/a> to the NIH Office of Technology Transfer.\u00a0 Each inventor stands to receive a personal payment of up to $150k annually<\/a> from the sales of mRNA-1273. NIAID also stands to earn millions of dollars<\/a> in revenue from the sale of mRNA-1273 in addition to what its inventors within NIAID earn personally.<\/div>\n
<\/div>\n
Moderna will pay a license fee to NIAID (or its parent agency) to use its patents related to mRNA-1273 and a portion of those fees are then paid directly to the inventors<\/a> within NIAID who developed those patents.<\/div>\n
<\/div>\n
There are two patents<\/a> for which the following six individuals in NIAID appear to be listed as inventors which relate to development of mRNA-1273:<\/div>\n
<\/div>\n